Climb Bio, Inc. (CLYM) Free cash flow 2024–2025
Climb Bio, Inc. (CLYM) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$54.5MFY2025 · since FY2024: -$15.6M → -$54.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$54.5M | -250.5% |
| FY2024 | -$15.6M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice